Pharmaceutical Microbiology Resources.
Edited by Professor Tim Sandle (established 2009)
Pages
▼
Tuesday, 15 December 2015
Dysbiosis and gynecologic cancers
Dysbiosis
is perturbation of the normal microbial flora in our body. It impacts many key
cellular metabolic processes resulting in multiple diseases including cancer.
Bacterial vaginosis, uterine cancer, ovarian cancer and endometrial cancer are
suspected to be promoted by dysbiotic microbiomes. How does dysbiosis ultimately
promote carcinogenesis? Read this comprehensive review on the microbiome and
cancer.
Related articles
1. Vaginal and gastrointestinal microbiomes in gynecologic cancers: a review, Chase et al., 2015
No comments:
Post a Comment
Pharmaceutical Microbiology Resources